25254 Federal Register / Vol. 74, No. 100 / Wednesday, May 27, 2009 / Notices 

Name of Committee: Center for Scientific 

Review, Special Emphasis Panel; Molecular 

and Cellular Processes of Neurodegeneration. 

Date: June 12, 2009. 

Time: 2 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Laurent Taupenot, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4188, 

MSC 7850, Bethesda, MD 20892, 301–435– 

1203, taupenol@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review, Special Emphasis Panel; Bacterial 

and Host Defenses. 

Date: June 12, 2009. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Georgetown Suites, 1111 30th Street, 

NW., Washington, DC 20007. 

Contact Person: Fouad A. El-Zaatari, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3206, 

MSC 7808, Bethesda, MD 20814–9692, (301) 

435–1149, elzaataf@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review, Special Emphasis Panel; ARRA 

Competive Revision Application Review. 

Date: June 12, 2009. 

Time: 2 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Allerton Hotel Chicago, 701 

North Michigan Avenue, Chicago, IL 60611. 

Contact Person: Jin Huang, PhD, Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 4095G, MSC 7812, Bethesda, 

MD 20892, 301–435–1230, jh377p@nih.gov. 

Name of Committee: Center for Scientific 

Review, Special Emphasis Panel; Member 

Conflicts-Psychosocial Development, Risk, 

and Prevention. 

Date: June 12, 2009. 

Time: 3 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call) 

Contact Person: Karen Lechter, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3128, 

MSC 7759, Bethesda, MD 20892, 301–496– 

0726, lechterk@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review, Special Emphasis Panel; MESH: 

Review of Competing Revisions. 

Date: June 12, 2009. 

Time: 5 p.m. to 7 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Warwick Seattle Hotel, 401 Lenora 

Street, Seattle, WA 98121. 

Contact Person: Maribeth Champoux, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3170, 

MSC 7848, Bethesda, MD 20892, 301–594– 

3163, champoum@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review, Special Emphasis Panel; Family 

Planning Service Delivery Improvement 

Research. 

Date: June 12, 2009. 

Time: 12 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call) 

Contact Person: Estina E. Thompson, PhD, 

MPH, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3178, 

MSC 7848, Bethesda, MD 20892, 301–496– 

5749, thompsone@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review, Special Emphasis Panel; Cell 

Biology Member SEP. 

Date: June 12, 2009. 

Time: 12 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call) 

Contact Person: Jonathan Arias, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5170, 

MSC 7840, Bethesda, MD 20892, 301–435– 

2406, ariasj@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review, Special Emphasis Panel; 

Competitive Revisions: Clinical 

Neuroimmunology and Brain Tumors. 

Date: June 12, 2009. 

Time: 12 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Melrose Hotel, 2430 Pennsylvania 

Avenue, NW., Washington, DC 20037. 

Contact Person: Jay Joshi, PhD, Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 5196, MSC 7846, Bethesda, MD 

20892, (301) 435–1184, joshij@csr.nih.gov. 

Name of Committee: Cardiovascular and 

Respiratory Sciences Integrated Review 

Group; Electrical Signaling, Ion Transport, 

and Arrhythmias Study Section. 

Date: June 14–15, 2009. 

Time: 7 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Westin St. Francis, 335 Powell 

Street, San Francisco, CA 94102. 

Contact Person: Rajiv Kumar, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4122, 

MSC 7802, Bethesda, MD 20892, 301–435– 

1212, kumarra@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: May 19, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–12244 Filed 5–26–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel, 

NHLBI Cardiac Development Consortium. 

Date: June 16, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

Bethesda, MD 20852. 

Contact Person: Tony L. Creazzo, PhD, 

Scientific Review Officer, Review Branch/ 

DERA, National Heart, Lung, and Blood 

Institute, 6701 Rockledge Drive, Room 7180, 

Bethesda, MD 20892–7924, 301–435–0725, 

creazzot@mail.nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel, 

Patient Oriented Research (K23, 24, and 25’s) 

Career Enhancement Awards. 

Date: June 16–17, 2009. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crystal City Marriott, 1999 Jefferson 

Davis Highway, Arlington, VA 22202. 

Contact Person: Mark Roltsch, PhD, 

Scientific Review Officer, Review Branch/ 

DERA, National Heart, Lung, and Blood 

Institute, 6701 Rockledge Drive, Room 7192, 

Bethesda, MD 20892–7924, 301–435–0287, 

roltschm@nhlbi.nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel, 

NHLBI Pediatric Translational Consortium 

Administrative Coordinating Center. 

Date: June 16, 2009. 

Time: 5 p.m. to 8 p.m. 

Agenda: To review and evaluate grant 

applications. 


erowe on PROD1PC63 with NOTICES
Federal Register / Vol. 74, No. 100 / Wednesday, May 27, 2009 / Notices 25255 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

Bethesda, MD 20852. 

Contact Person: Tony L. Creazzo, PhD, 

Scientific Review Officer, Review Branch/ 

DERA, National Heart, Lung, and Blood 

Institute, 6701 Rockledge Drive, Room 7180, 

Bethesda, MD 20892–7924, 301–435–0725, 

creazzot@mail.nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel, 

NHLBI Pediatric Cardiac Genomics 

Consortium. 

Date: June 17, 2009. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

Bethesda, MD 20852. 

Contact Person: Tony L. Creazzo, PhD, 

Scientific Review Officer, Review Branch/ 

DERA, National Heart, Lung, and Blood 

Institute, 6701 Rockledge Drive, Room 7180, 

Bethesda, MD 20892–7924, 301–435–0725, 

creazzot@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: May 19, 2009 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–12242 Filed 5–26–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of Biotechnology Activities, 

Office of Science Policy, Office of the 

Director; Notice of Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a public 

teleconference of the National Science 

Advisory Board for Biosecurity 

(NSABB). 

Under authority 42 U.S.C. 217a, 

section 222 of the Public Health Service 

Act, as amended, the Department of 

Health and Human Services established 

NSABB to provide advice, guidance and 

leadership regarding Federal oversight 

of dual use research, defined as 

biological research with legitimate 

scientific purposes that could be 

misused to pose a biological threat to 

public health and/or national security. 

A publicly accessible teleconference 

line will be available for the meeting. 

Name of Committee: National Science 

Advisory Board for Biosecurity. 

Date: May 27, 2009. 

Open: 1 p.m. to 2:30 p.m. 

Agenda: Presentations and discussions 

regarding revisions to the draft NSABB report 

on Enhancing Personnel Reliability among 

Individuals with Access to Select Agents and 

Toxins. 

Place: National Institutes of Health, Office 

of Biotechnology Activities, Suite 750, 

Bethesda, Maryland 20892. (Telephone 

Conference Call). 

Call-in Information: Toll-Free Number: 1– 

800–988–9458. Participant Passcode: 

NSABB. 

Contact Person: Ronna Hill, NSABB 

Program Assistant, 6705 Rockledge Drive, 

Bethesda, Maryland 20892. (301) 496–9838. 

The teleconference meeting agenda, 

revised draft report and other information 

about the NSABB will be available at 

http://www.biosecurityboard.gov Please 

check this Web site for updates. 

The teleconference will include 

opportunity for public comment. In addition, 

any interested person may file written 

comments with the committee. All written 

comments must be received by May 26, 2009 

and should be sent via e-mail to 

nsabb@od.nih.gov with ‘‘NSABB Public 

Comment’’ as the subject line or by regular 

mail to 6705 Rockledge Drive, Suite 750, 

Bethesda, MD 20892, Attention: Ronna Hill. 

The statement should include the name, 

address, telephone number and, when 

applicable, the business or professional 

affiliation of the interested person. 

This notice is being published less than 15 

days prior to the meeting due to time 

restraints placed on Committee deliberations. 

Dated: May 18, 2009. 

Jennifer Spaeth, 

Office of Federal Advisory Committee Policy. 

[FR Doc. E9–12275 Filed 5–26–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Initial Review Group; Diabetes, 

Endocrinology and Metabolic Diseases B 

Subcommittee. 

Date: June 13–14, 2009. 

Open: June 13, 2009, 5:30 p.m. to 6 p.m. 

Agenda: To review procedures and discuss 

policy. 

Place: Four Points Sheraton, 1201 K Street, 

NW., Washington, DC 20005. 

Closed: June 13, 2009, 6:00 p.m. to 9:30 

p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Four Points Sheraton, 1201 K Street, 

NW., Washington, DC 20005. 

Closed: June 14, 2009, 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Four Points Sheraton, 1201 K Street, 

NW., Washington, DC 20005. 

Contact Person: John F. Connaughton, PhD, 

Chief, Chartered Committees Section, Review 

Branch, DEA, NIDDK, National Institutes of 

Health, Room 753, 6707 Democracy 

Boulevard, Bethesda, MD 20892–5452, (301) 

594–7797, 

connaughtonj@extra.niddk.nih.gov. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Initial Review Group; Digestive Diseases and 

Nutrition C Subcommittee. 

Date: June 17–18, 2009. 

Open: June 17, 2009, 8 a.m. to 8:30 a.m. 

Agenda: To review procedures and discuss 

policy. 

Place: Georgetown Suites, 1000 29th Street 

NW., Washington, DC 20007. 

Closed: June 17, 2009, 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Georgetown Suites, 1000 29th Street 

NW., Washington, DC 20007. 

Closed: June 18, 2009, 8 a.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Georgetown Suites, 1000 29th Street, 

NW., Washington, DC 20007. 

Contact Person: Dan E. Matsumoto, PhD, 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes of Health, 

Room 749, 6707 Democracy Boulevard, 

Bethesda, MD 20892–5452, (301) 594–8894, 

matsumotod@extra.niddk.nih.gov. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Initial Review Group; Kidney, Urologic and 

Hematologic Diseases D Subcommittee. 

Date: June 24–25, 2009. 

Open: June 24, 2009, 8 a.m. to 8:30 a.m. 

Agenda: To review procedures and discuss 

policy. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 


erowe on PROD1PC63 with NOTICES